Gossamer Bio
(NASDAQ) GOSS
Gossamer Bio Financials at a Glance
Market Cap
$82.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$55.54M
Net Income (TTM)
-$180.40M
EPS (TTM)
-$0.79
P/E Ratio
-0.21
Dividend
$0.00
Beta (Volatility)
1.97 (High)
Dividend
$0.00
Beta (Volatility)
1.97 (High)
Price
$0.17
Volume
2,802,259.987
Open
$0.17
Price
$0.17
Volume
2,802,259.987
Open
$0.17
Previous Close
$0.17
Daily Range
$0.17 - $0.18
52-Week Range
$0.14 - $3.87
Estimated Earnings Date
Aug 4, 2026
Dividend
$0.00
Beta (Volatility)
1.97 (High)
Price
$0.17
Volume
2,802,259.987
Open
$0.17
Previous Close
$0.17
Daily Range
$0.17 - $0.18
52-Week Range
$0.14 - $3.87
Estimated Earnings Date
Aug 4, 2026
GOSS News
Is Gossamer Bio a Buy?
GOSS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gossamer Bio
Industry
Biotechnology
Sector
Health CareEmployees
162
CEO
Faheem Hasnain
Website
www.gossamerbio.comHeadquarters
San Diego, CA 92121, US
GOSS Financials
Key Financial Metrics (TTM)
Gross Margin
99.58%
Operating Margin
-321.92%
Net Income Margin
-324.82%
Return on Equity
174.85%
Return on Capital
-203.69%
Return on Assets
-139.95%
Earnings Yield
-4.76%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$82.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
488.85M
Volume
2.80M
Avg. Volume
12.48M
Financials (TTM)
Gross Profit
$55.30M
Operating Income
-$178.79M
EBITDA
-$168.81M
Operating Cash Flow
-$170.26M
Capital Expenditure
-$53.00K
Free Cash Flow
-$170.32M
Cash & ST Invst.
$99.22M
Total Debt
$202.93M
Gossamer Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.96M
+71.5%
Gross Profit
$16.72M
+69.1%
Gross Margin
98.63%
N/A
Market Cap
$82.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$509.97K
N/A
Employees
162
N/A
Net Income
-$46.66M
-27.4%
EBITDA
-$43.68M
-30.2%
Quarterly Fundamentals
Total Cash
$99.22M
-61.5%
Total Debt
$202.93M
+0.1%
Accounts Receivable
$9.35M
+42.1%
Inventory
$0.00
N/A
Long Term Debt
$201.98M
+0.0%
Short Term Debt
$957.00K
+12.2%
Return on Assets
-1.40%
N/A
Return on Invested Capital
-2.47%
N/A
Free Cash Flow
-$38.72M
+2.6%
Operating Cash Flow
-$38.72M
+2.5%